• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个稳健的免疫相关基因对特征可用于预测食管癌的总生存期。

A robust immune-related gene pairs signature for predicting the overall survival of esophageal cancer.

机构信息

Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Department of Nutrition and Food Hygiene, Chongqing Medical University, Chongqing, China.

出版信息

BMC Genomics. 2023 Jul 10;24(1):385. doi: 10.1186/s12864-023-09496-x.

DOI:10.1186/s12864-023-09496-x
PMID:37430202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10332031/
Abstract

BACKGROUND

Identifying reliable biomarkers could effectively predict esophagus carcinoma (EC) patients with poor prognosis. In this work, we constructed an immune-related gene pairs (IRGP) signature to evaluate the prognosis of EC.

RESULTS

The IRGP signature was trained by the TCGA cohort and validated by three GEO datasets, respectively. Cox regression model together with LASSO was applied to construct the overall survival (OS) associated IRGP. 21 IRGPs consisting of 38 immune-related genes were included in our signature, according to which patients were stratified into high- and low-risk groups. The results of Kaplan-Meier survival analyses indicated that high-risk EC patients had worse OS than low-risk group in the training set, meta-validation set and all independent validation datasets. After adjustment in multivariate Cox analyses, our signature continued to be an independent prognostic factor of EC and the signature-based nomogram could effectively predict the prognosis of EC sufferers. Besides, Gene Ontology analysis revealed this signature is related to immunity. 'CIBERSORT' analysis revealed the infiltration levels of plasma cells and activated CD4 memory T cells in two risk groups were significantly different. Ultimately, we validated the expression levels of six selected genes from IRGP index in KYSE-150 and KYSE-450.

CONCLUSIONS

This IRGP signature could be applied to select EC patients with high mortality risk, thereby improving prospects for the treatment of EC.

摘要

背景

识别可靠的生物标志物可以有效地预测食管癌(EC)预后不良的患者。在这项工作中,我们构建了一个免疫相关基因对(IRGP)特征来评估 EC 的预后。

结果

IRGP 特征由 TCGA 队列进行训练,并分别由三个 GEO 数据集进行验证。Cox 回归模型和 LASSO 一起被用来构建与总体生存(OS)相关的 IRGP。根据该模型,我们的特征包含 21 个由 38 个免疫相关基因组成的基因对,根据这些基因对患者被分为高风险和低风险组。Kaplan-Meier 生存分析的结果表明,在训练集、meta 验证集和所有独立验证数据集中,高风险 EC 患者的 OS 明显差于低风险组。在多变量 Cox 分析调整后,我们的特征仍然是 EC 的独立预后因素,基于该特征的列线图可以有效地预测 EC 患者的预后。此外,GO 分析表明该特征与免疫有关。'CIBERSORT'分析显示,两个风险组的浆细胞和活化的 CD4 记忆 T 细胞的浸润水平有显著差异。最后,我们验证了 IRGP 指数中 6 个选定基因在 KYSE-150 和 KYSE-450 中的表达水平。

结论

这个 IRGP 特征可以用来选择具有高死亡率风险的 EC 患者,从而改善 EC 的治疗前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/f0142da95036/12864_2023_9496_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/f71ebe7dd957/12864_2023_9496_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/8cbdfb5e31ff/12864_2023_9496_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/f9ea991ba04e/12864_2023_9496_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/b8120ab0771c/12864_2023_9496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/8661dc082d54/12864_2023_9496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/56cd34130d2e/12864_2023_9496_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/82cd73db7edf/12864_2023_9496_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/f0142da95036/12864_2023_9496_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/f71ebe7dd957/12864_2023_9496_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/8cbdfb5e31ff/12864_2023_9496_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/f9ea991ba04e/12864_2023_9496_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/b8120ab0771c/12864_2023_9496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/8661dc082d54/12864_2023_9496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/56cd34130d2e/12864_2023_9496_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/82cd73db7edf/12864_2023_9496_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/931d/10332031/f0142da95036/12864_2023_9496_Fig8_HTML.jpg

相似文献

1
A robust immune-related gene pairs signature for predicting the overall survival of esophageal cancer.一个稳健的免疫相关基因对特征可用于预测食管癌的总生存期。
BMC Genomics. 2023 Jul 10;24(1):385. doi: 10.1186/s12864-023-09496-x.
2
Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.基于免疫基因对的特征在食管癌预后及免疫治疗预测中的研究进展
Ann Transl Med. 2021 Oct;9(20):1591. doi: 10.21037/atm-21-5217.
3
Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients.免疫相关基因对特征在原发性低级别胶质瘤患者中的预后和预测价值
Front Oncol. 2021 May 27;11:665870. doi: 10.3389/fonc.2021.665870. eCollection 2021.
4
Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.鉴定用于预测膀胱癌预后和免疫治疗疗效的IRGP特征
Front Mol Biosci. 2021 Apr 15;8:607090. doi: 10.3389/fmolb.2021.607090. eCollection 2021.
5
Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.子宫内膜癌中五免疫基因对标志物的建立与验证。
Comb Chem High Throughput Screen. 2021;24(2):233-245. doi: 10.2174/1386207323999200729113641.
6
A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.基于检查淋巴结数量相关特征的列线图模型预测胃癌的预后并指导临床治疗。
Front Immunol. 2022 Nov 2;13:947802. doi: 10.3389/fimmu.2022.947802. eCollection 2022.
7
Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.基于 14 对免疫相关基因对的综合分析构建signature,预测胃癌的预后和免疫特征。
Int Immunopharmacol. 2020 Dec;89(Pt B):107074. doi: 10.1016/j.intimp.2020.107074. Epub 2020 Oct 10.
8
Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.利用免疫相关基因对signature 预测黑色素瘤的临床结局。
PLoS One. 2020 Oct 8;15(10):e0240331. doi: 10.1371/journal.pone.0240331. eCollection 2020.
9
A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.14个免疫相关基因对的特征可预测胃癌的总生存期。
Clin Transl Oncol. 2021 Feb;23(2):265-274. doi: 10.1007/s12094-020-02414-7. Epub 2020 Jun 9.
10
Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature.基于免疫相关基因对signature 预测皮肤黑色素瘤的临床预后
Bioengineered. 2021 Dec;12(1):1803-1812. doi: 10.1080/21655979.2021.1924556.

引用本文的文献

1
An immune-related gene pair signature predicts the prognosis and immunotherapeutic response in glioblastoma.一种免疫相关基因对特征可预测胶质母细胞瘤的预后和免疫治疗反应。
Heliyon. 2024 Oct 5;10(19):e39025. doi: 10.1016/j.heliyon.2024.e39025. eCollection 2024 Oct 15.

本文引用的文献

1
Gene function and cell surface protein association analysis based on single-cell multiomics data.基于单细胞多组学数据的基因功能与细胞表面蛋白关联分析
Comput Biol Med. 2023 May;157:106733. doi: 10.1016/j.compbiomed.2023.106733. Epub 2023 Mar 1.
2
Investigating cardiotoxicity related with hERG channel blockers using molecular fingerprints and graph attention mechanism.使用分子指纹和图注意力机制研究与hERG通道阻滞剂相关的心脏毒性。
Comput Biol Med. 2023 Feb;153:106464. doi: 10.1016/j.compbiomed.2022.106464. Epub 2022 Dec 20.
3
Predicting the potential human lncRNA-miRNA interactions based on graph convolution network with conditional random field.
基于条件随机场的图卷积网络预测潜在的人类 lncRNA-miRNA 相互作用。
Brief Bioinform. 2022 Nov 19;23(6). doi: 10.1093/bib/bbac463.
4
Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy.全基因组DNA甲基化和基因表达谱分析鉴定食管鳞状细胞癌的分子亚型以预测患者生存及免疫治疗疗效
Cancers (Basel). 2022 Oct 11;14(20):4970. doi: 10.3390/cancers14204970.
5
A deep learning method for predicting metabolite-disease associations via graph neural network.基于图神经网络的代谢物-疾病关联预测深度学习方法。
Brief Bioinform. 2022 Jul 18;23(4). doi: 10.1093/bib/bbac266.
6
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression.实验与计算模型用于发现肾细胞癌进展的特征和生物标志物。
Mol Cancer. 2021 Oct 20;20(1):136. doi: 10.1186/s12943-021-01416-5.
7
Identification of plasma SAA2 as a candidate biomarker for the detection and surveillance of non-small cell lung cancer.鉴定血浆 SAA2 作为非小细胞肺癌检测和监测的候选生物标志物。
Neoplasma. 2021 Nov;68(6):1301-1309. doi: 10.4149/neo_2021_210228N263. Epub 2021 Oct 13.
8
Identification of Claudin-6 as a Molecular Biomarker in Pan-Cancer Through Multiple Omics Integrative Analysis.通过多组学综合分析鉴定Claudin-6作为泛癌中的分子生物标志物
Front Cell Dev Biol. 2021 Aug 2;9:726656. doi: 10.3389/fcell.2021.726656. eCollection 2021.
9
The role of YTH domain containing 2 in epigenetic modification and immune infiltration of pan-cancer.YTH 结构域包含蛋白 2 在泛癌的表观遗传修饰和免疫浸润中的作用。
J Cell Mol Med. 2021 Sep;25(18):8615-8627. doi: 10.1111/jcmm.16818. Epub 2021 Jul 27.
10
A united risk model of 11 immune‑related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients.11 对免疫相关基因与临床分期联合风险模型预测透明细胞肾细胞癌患者的总生存期。
Bioengineered. 2021 Dec;12(1):4259-4277. doi: 10.1080/21655979.2021.1955558.